2012 FULL YEAR. Results Presentation. Investor Road Show May 2012

Transcription

1 2012 FULL YEAR Rsults Prsntation Invstor Road Show May 2012

2 IMPORTANT NOTICE AND DISCLAIMER This prsntation has bn prpard by Campbll Brothrs Limitd, (CBL or th Company). It contains gnral information about th Company s activitis as at th dat of th prsntation. It is information givn in summary form and dos not purport to b complt. Th distribution of this prsntation in jurisdictions outsid Australia may b rstrictd by law, and you should obsrv any such rstrictions. This prsntation is not, and nothing in it should b construd as, an offr, invitation or rcommndation in rspct of scuritis, or an offr, invitation or rcommndation to sll, or a solicitation of an offr to buy, scuritis in any jurisdiction. Nithr this documnt nor anything in it shall form th basis of any contract or commitmnt. This prsntation is not intndd to b rlid upon as advic to invstors or potntial invstors and dos not tak into account th invstmnt objctivs, financial situation or nds of any invstor. All invstors should considr such factors in consultation with a profssional advisor of thir choosing whn dciding if an invstmnt is appropriat. Th Company has prpard this prsntation basd on information availabl to it, including information drivd from public sourcs that hav not bn indpndntly vrifid. No rprsntation or warranty, xprss or implid, is providd in rlation to th fairnss, accuracy, corrctnss, compltnss or rliability of th information, opinions or conclusions xprssd hrin. This prsntation includs forward-looking statmnts within th maning of scuritis laws. Any forwardlooking statmnts involv known and unknown risks and uncrtaintis, many of which ar outsid th control of th Company and its rprsntativs. Forward-looking statmnts may also b basd on stimats and assumptions with rspct to futur businss dcisions, which ar subjct to chang. Any statmnts, assumptions, opinions or conclusions as to futur mattrs may prov to b incorrct, and actual rsults, prformanc or achivmnt may vary matrially from any projctions and forward-looking statmnts. Du car and attntion should b undrtakn whn considring and analysing th financial prformanc of th Company. All rfrncs to dollars ar to Australian currncy unlss othrwis statd. 2

3 March 2012 Full Yar Snapshot pr unusual itms FY08 FY09 FY10 FY11 FY REVENUE 31 st March 2012 $1406mn 27 % FY08 FY09 FY10 FY11 FY EBITDA 31 st March 2012 $374mn 57 % FY08 FY09 FY10 FY11 FY NPAT 31 st March 2012 $222mn 68 % 3 FY08 FY09 FY10 FY11 FY12 Avrag USD:AUD (cnts)

4 Full Yar Rsults Ovrviw xcluding unusual itms Mar 12 Mar 11 Chang Rvnu ($mn) 1,406 1, % EBITDA ($mn) % Profit bfor tax ($mn) % Nt profit aftr tax ($mn) % Wtd. av. numbr of shars 67,503,000 65,139,000 +4% Earnings pr shar (c) % Full Yar Dividnd (c) % Numbr of mploys Includs full tim, part tim and casuals 12,101 8, % Safty Statistic LTIFR

5 Yar End March Maintaining Dividnd Growth Maintnanc of Dividnd Policy 2003 $0.00 $0.20 $0.40 $0.60 $0.80 $1.00 $1.20 $1.40 $1.60 $1.80 $2.00 $2.20 $ Total dividnd $ % payout ratio 5

6 Total Sharholdr Rturn last thr yar priod Campbll Brothrs Boart Longyar Cor Laboratoris Monadlphous Cardno Intrtk Burau Vritas MacMahon Orica Eurofins Clough Worly Parsons Ausnco SGS Transfild Srvics Srvcorp Coffy -100% 0% 100% 200% 300% 400% 500% 600% 700% Total Sharholdr Rturn (1st April 2009 to 31st March 2012) Sourc- Ernst & Young 6

7 ALS - Nw Divisional Structur - Four Global Divisions - Tn Businss Strams 7% 13% 49% 31% Rvnu by Division 7

8 Rvnu (AUD million) EBITDA & EBIT (AUD million) ALS Group Full Yar Snapshot Avrag USD:AUD (cnts) REVENUE 31 st March 2012 $1192mn 39 % EBITDA st March 2012 $385mn 54 % EBIT 8 0 FY08 FY09 FY10 FY11 FY12 Rvnu EBITDA EBIT 0 31 st March 2012 $341mn 61 %

9 AUD$ millions AUD$ millions Growth of non-minrals Divisions Rvnu EBITDA (incl ALS ovrhads) 1,400 1, Non-Minral EBITDA margin 21% 21% 24% 20% 24% 23% 25% 1, FY06 FY07 FY08 FY09 FY10 FY11 FY12 - FY06 FY07 FY08 FY09 FY10 FY11 FY12 9 Lif Scincs Enrgy Industrial Minrals Th non-minrals rvnu of ALS is now largr than ALS ntir rvnu only two yars ago and th Minrals Division has bn transformd from a gochmical only businss in 2009 to a gochmical, mtallurgical and inspction businss in 2012.

10 ALS Rvnu AUD $million ALS Group Rvnu Prformanc Rvnu by Gography FY11 Vs FY12 9% Rportd Growth 39% Constant Currncy Growth 46% 6% 5% 7% 5% 5% 32% 32% 5% 4% 44% 46% Australia Asia Nth Amrica Sth Amrica Africa Europ Rvnu by Division FY11 Vs FY12 0 FY 2011 Organic Acquird FX FY % 17% 7% 8% 39% 49% Minrals Lif Scincs Enrgy 31% 36% Industrial 10

11 ALS Group Prformanc 40% 35% 30% 25% 20% 15% 10% 5% 0% EBIT Margin (incl. ALS ovrhads) Minrals Lif Scincs Enrgy Industrial FY2011 FY2012 Rvnu Growth Industrial Enrgy Lif Scincs Minrals -20% -10% 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% Organic Acquird FX Impact 11

12 Minrals Division 12 r v n u Chang Rvnu $591mn $334mn 77% EBITDA $234mn $127mn 84% EBIT $215mn $112mn 92% EBIT Margin 36.3% 33.4% +290bps Gochmistry Mtallurgy Inspction Othr Ovrviw Acquisition (AUD$222mn) and intgration of Stwart Group vry succssful 16 nw or rfurbishd laboratoris compltd Succssful introduction of CorViwr TM Expansion in cntral Asia Significant capacity incras in Kamloops mtallurgical laboratory Pricing stabilisd Outlook Favourabl markt conditions through nw or rfurbishd laboratoris plannd Nw 7000 m 2 Santiago gochmistry and mtallurgical laboratory to b oprational by January 2013 High Prssur Acid Lach pilot plant to b installd in Prth Nw hub laboratory in Irland Iron Or Tchnical Cntr to b built in Prth Commissioning of nw hub lab in Johannsburg by July 2012

13 Lif Scincs Division r v n u Chang Rvnu $361mn $308mn 17% EBITDA $96mn $82mn 17% EBIT $78mn $66mn 18% EBIT Margin 21.7% 21.5% +20bps Australia Asia Nth Amrica Europ * Includs a full yar for CAS acquisition in North Amrica Ovrviw Acquisition (AUD$40mn) and intgration of Columbia Analytical Srvics vry succssful Acquisition (AUD$40mn) of Eclips and AMS compltd in April 2012 Introducd mobil app for nvironmntal clints Australian and Scandinavian markts strong Outlook Focus on xpanding food/pharma rvnus Nw food/pharma laboratoris in Mlbourn, Sydny & Brisban Rfurbish or nw nvironmntal laboratoris in Brisban, Sydny, Calgary, Singapor, Hong Kong, Kuala Lumpur, Jakarta Furthr dvlopmnt of air markts Nw gnration LIMS to b rolld out to all laboratoris ovr nxt two yars 13

14 Enrgy Division r v n u Chang Rvnu $88mn $73mn 20% EBITDA $26.6mn $19.9mn 34% EBIT $23.7mn $17.2mn 38% EBIT Margin 26.9% 23.6% +330bps Australia Asia Nth Amrica Africa Ovrviw Excllnt yar, far xcding industry growth rats Laboratory industry lading safty rcord; LTIFR = 2.4 Full commissioning of th nw Brisban laboratory th largst coal analytical laboratory in th world Nw laboratoris built in Emrald and Bown Nw LIMS rolld out to all Australian laboratoris Succssful intgration of th anglo Amrican Cntral Laboratory in South Africa and th Stwart Group laboratory in Mongolia Outlook Nw Enrgy Division cratd to focus attntion on oil and gas upstram opportunitis Furthr capacity build out of Brisban laboratory Expansion into Indonsia undrway with Mozambiqu, China and USA undr considration Nw sit with largr capacity bing dvlopd in Mongolia 14

15 Industrial Division Chang Rvnu $153mn $142mn 8% EBITDA $29.0mn $20.6mn 41% EBIT $24.5mn $16.6mn 48% EBIT Margin 16.0% 11.7% +430bps r v n u Australia Sth Amrica Nth Amrica Africa Ovrviw Strong yar lvrag off continuing improvmnt from prvious yar Disposal of ParlStrt Enrgy Srvics allows focus on Asst Car businss Acquistion (AUD$40mn )of PowrSrvics vry succssful Strong margin improvmnt Advancd Enginring Srvics modl rolld out A numbr of major shutdown projcts dlayd into Dlays on som major infrastructur projcts prviously won Outlook Focus on xpansion of businss outsid of Australia Introduction of furthr high-nd tchnologis Continud markt and markt shar growth 15

16 Campbll Chmical Division Chang Rvnu $90mn $130mn (31)% EBITDA $8.8mn $9.8mn (10)% EBIT $8.1mn $7.4mn 9% EBIT Margin 9.0% 5.7% +330bps Ovrviw Rcord sals and oprating profit for th Panamx Group Rvnu down as a rsult of Clantc disposal Strong sals in Papua Nw Guina Bttr cost control across all businss sits Dltrx sals in Australia subdud du to contraction in manufacturing sctor, customr factory closurs and advrs wathr Som on off costs incurrd in dcoupling th Clantc businss Outlook Panamx xpcting a strong yar with furthr growth in Papua Nw Guina and th Frnch trritoris Dltrx xpcting modst growth with opportunitis in th rsourcs sctor 16

17 Rward Distribution Division Chang Rvnu $123mn $124mn (0.6)% EBITDA $4.5mn ($0.6)mn N.A. EBIT $3.7mn ($1.8)mn N.A. EBIT Margin 3.0% (1.5)% +450bps Ovrviw Significant turnaround from prvious yar Excluding discontinud Nw Zaland oprations, rvnu up 3.8% in Australia on prvious yar Rduction in invntory Disposal of undrprforming Nw Zaland oprations Strong import program Incras in productivity and lowr had count Succssful rollout of Th Hospitality Stors Outlook Furthr growth in rvnu and margin in Import program xtndd with broadning of ownd brands Improvd markt conditions in mining and hospitality 17

18 Organic Invstmnt Paying Off Rturn on Equity CAPEX (AUD$mn) 28% 83 23% 25% % 50 14% 43 FY2008 FY2009 FY2010 FY2011 FY2012 FY2008 FY2009 FY2010 FY2011 FY

19 AUD $million Funding Strngth Dbt Maturity Profil Bank Bank Capacity USPP Yar Not: Garing dfind as Nt Dbt as a prcntag of Nt Dbt plus Equity was 28% at th 31 st March 2012